Key result
High-dose intravenous haloperidol controls severe agitation safely in coronary care unit patients.
Case Report (n=4)
Answers are grounded in this paper and cite their sources.
Although previous reports have documented the safe and effective use of intravenous haloperidol in agitated cardiac patients, the dosages advocated have in general been relatively low: 1 to 2 mg every 2 to 4 hours. In this report, the authors demonstrate that such doses may be insufficient to control severe agitation in coronary care unit patients. Four cases are presented in which more than 100 mg/day of intravenous haloperidol were required for safe and effective control of confusion and agitation.
No takes yet. Share an insight, caveat, or question.
Tesar et al. (1985) conducted a case report in Severe agitation and confusion (n=4). Intravenous haloperidol was evaluated on Safe and effective control of confusion and agitation. High-dose intravenous haloperidol (>100 mg/day) was required for safe and effective control of severe confusion and agitation in four coronary care unit patients.
Synapse has enriched 10 related papers. Consider them for comparative context: